Skip to content

Preliminary study on the molecular mechanism of placental accreta spectrum

Preliminary study on the molecular mechanism of placental accreta spectrum

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023595
Enrollment
Unknown
Registered
2019-06-03
Start date
2019-06-04
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placental accreta spectrum

Interventions

normal intrauterine pregnancy:non
cesarean sar pregnancy:non
normal intrauterine pergnancy with history of cesarean section:non

Sponsors

Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18-45 years; 2. Intrauterine pregnancy was confirmed by ultrasound at 5-10 weeks; 3. Termination gestation due to unplanned pregnancy; 4. Willing to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, lung, kidney, blood system and other important organ diseases; 2. Those who do not choose artificial abortion.

Design outcomes

Primary

MeasureTime frame
mRNA;

Countries

China

Contacts

Public ContactChen Zhengqiong

Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Army Medical University

Chenzhengqiong75@163.com+86 13883322771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026